PURPOSE: Human eyes with exfoliation syndrome (XFS) exhibit a distinctive pattern of iris transillumination defects that are recapitulated in Lyst mutant mice carrying the beige allele. The purpose of this study was to determine the anatomic basis for Lyst-mediated transillumination defects, test whether Lyst mutant mice develop other features of XFS, and describe the molecular basis of the beige mutation. METHODS: Lyst mutant mice and strain-matched controls were compared by clinical, histologic, immunohistochemical, and molecular genetic analyses. RESULTS: Slit-lamp examination showed that Lyst mutant mice uniformly exhibit XFS-like transillumination defects. Histologic analysis showed that these defects correlate with a sawtooth morphology of the iris pigment epithelium. Lyst mutant mice also produce an exfoliative-like material and exhibit pronounced pigment dispersion. Despite these insults, Lyst mutation does not cause increased intraocular pressure or optic nerve damage in the C57BL/6J genetic background. Sequence analysis identified that the beige mutation is predicted to delete a single isoleucine from the WD40 domain of the LYST protein, suggesting that this mutation is likely to disrupt a protein-protein interaction. CONCLUSIONS: Lyst mutant eyes exhibit multiple features of XFS. Recent human genetic association studies have identified changes occurring in the LOXL1 gene as an important risk factor for XFS but also indicated that other factors contributing to risk likely exist. These results demonstrated that mutation of the Lyst gene can produce ocular features of human XFS and suggested that LYST or LYST-interacting genes may contribute to XFS.
PURPOSE:Human eyes with exfoliation syndrome (XFS) exhibit a distinctive pattern of iris transillumination defects that are recapitulated in Lyst mutant mice carrying the beige allele. The purpose of this study was to determine the anatomic basis for Lyst-mediated transillumination defects, test whether Lyst mutant mice develop other features of XFS, and describe the molecular basis of the beige mutation. METHODS:Lyst mutant mice and strain-matched controls were compared by clinical, histologic, immunohistochemical, and molecular genetic analyses. RESULTS: Slit-lamp examination showed that Lyst mutant mice uniformly exhibit XFS-like transillumination defects. Histologic analysis showed that these defects correlate with a sawtooth morphology of the iris pigment epithelium. Lyst mutant mice also produce an exfoliative-like material and exhibit pronounced pigment dispersion. Despite these insults, Lyst mutation does not cause increased intraocular pressure or optic nerve damage in the C57BL/6J genetic background. Sequence analysis identified that the beige mutation is predicted to delete a single isoleucine from the WD40 domain of the LYST protein, suggesting that this mutation is likely to disrupt a protein-protein interaction. CONCLUSIONS:Lyst mutant eyes exhibit multiple features of XFS. Recent human genetic association studies have identified changes occurring in the LOXL1 gene as an important risk factor for XFS but also indicated that other factors contributing to risk likely exist. These results demonstrated that mutation of the Lyst gene can produce ocular features of human XFS and suggested that LYST or LYST-interacting genes may contribute to XFS.
Authors: Fabian Runkel; Heinrich Büssow; Kevin L Seburn; Gregory A Cox; Diane McVey Ward; Jerry Kaplan; Thomas Franz Journal: Mamm Genome Date: 2006-03-03 Impact factor: 2.957
Authors: Pratap Challa; Silke Schmidt; Yutao Liu; Xuejun Qin; Robin R Vann; Pedro Gonzalez; R Rand Allingham; Michael A Hauser Journal: Mol Vis Date: 2008-01-29 Impact factor: 2.367
Authors: Adrian A Lahola-Chomiak; Tim Footz; Kim Nguyen-Phuoc; Gavin J Neil; Baojian Fan; Keri F Allen; David S Greenfield; Richard K Parrish; Kevin Linkroum; Louis R Pasquale; Ralf M Leonhardt; Robert Ritch; Shari Javadiyan; Jamie E Craig; W T Allison; Ordan J Lehmann; Michael A Walter; Janey L Wiggs Journal: Hum Mol Genet Date: 2019-04-15 Impact factor: 6.150
Authors: Harald M Stauss; Kevin R Rarick; Katie M Leick; Jason W Burkle; Diane L Rotella; Michael G Anderson Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-03-09 Impact factor: 3.619
Authors: Colleen M Trantow; Tryphena L Cuffy; John H Fingert; Markus H Kuehn; Michael G Anderson Journal: Invest Ophthalmol Vis Sci Date: 2011-01-05 Impact factor: 4.799
Authors: Gulab S Zode; Markus H Kuehn; Darryl Y Nishimura; Charles C Searby; Kabhilan Mohan; Sinisa D Grozdanic; Kevin Bugge; Michael G Anderson; Abbot F Clark; Edwin M Stone; Val C Sheffield Journal: J Clin Invest Date: 2011-08-08 Impact factor: 14.808
Authors: Kimberly A Fernandes; Jeffrey M Harder; Pete A Williams; Rebecca L Rausch; Amy E Kiernan; K Saidas Nair; Michael G Anderson; Simon W M John; Gareth R Howell; Richard T Libby Journal: Exp Eye Res Date: 2015-06-24 Impact factor: 3.467
Authors: John H Fingert; James H Burden; Kai Wang; Young H Kwon; Wallace L M Alward; Michael G Anderson Journal: J Glaucoma Date: 2013-09 Impact factor: 2.503
Authors: Fan Liu; Andreas Wollstein; Pirro G Hysi; Georgina A Ankra-Badu; Timothy D Spector; Daniel Park; Gu Zhu; Mats Larsson; David L Duffy; Grant W Montgomery; David A Mackey; Susan Walsh; Oscar Lao; Albert Hofman; Fernando Rivadeneira; Johannes R Vingerling; André G Uitterlinden; Nicholas G Martin; Christopher J Hammond; Manfred Kayser Journal: PLoS Genet Date: 2010-05-06 Impact factor: 5.917
Authors: Colleen M Trantow; Adam Hedberg-Buenz; Sachiyo Iwashita; Steven A Moore; Michael G Anderson Journal: PLoS Genet Date: 2010-07-01 Impact factor: 5.917